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dimer interface as eIF2α, related by crystal packing, it
is still not in an active conformation. It is not autophos-
phorylated and in the absence of phosphorylation of
the activation loop, the conserved Glu643 residue of
the αC-helix actually interacts with the HRD Arg834.
GCN2 thus remains in an inactive conformation. Clearly
dimerization is not sufficient to promote autophosphor-
ylation or to snap the αC-helix into its active conforma-
tional state. GCN2, but not PERK and HRI, lacks both
basic residues in the αC-helix, and this may explain
why activation is not achieved so readily by simple di-
merization. Although the precise mechanism remains to
be elucidated, dimerization and phosphorylation of the
activation loop appear to be closely linked for PKR,
with dimerization being an essential first step.
Binding of a signal molecule to the N-terminal regula-
tory domain promotes dimerization and activation of
each eIF2α kinase. PKR is activated by the binding of
dsRNA to the N-terminal regulatory domain. In both the
PKR and the GCN2 structures, the regulatory domain
has been deleted. Therefore, how binding of dsRNA
promotes PKR dimerization and activation cannot be
resolved and is largely overlooked in these papers. In
addition, the eIF2α kinases have a long β4-β5 linker.
In both cases, this segment was truncated and what
remains is disordered. Both regions could contribute
directly to the activation mechanism; without the full-
length structures it is premature to speculate on the
ordered pathway for activation. Is the activation loop
locked into an inhibited conformation in the absence of
dsRNA in a way that involves the regulatory N-terminal
domain or the β4-β5 linker? Does binding of dsRNA
then release the inhibition? From the structure and mu-
tagenesis studies it is clear that the allosteric mecha-
nism for activation of the eIF2α kinases involves a tight
and dynamic interaction between dimerization, auto-
phosphorylation, and substrate docking. These studies
reveal the intricacy of this integration and also demon-
strate how phosphorylation of the activation loop can
allosterically couple two remote sites.
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CDKs Give Cdc6 a License
to Drive into S Phase
The accumulation of Cdc6 promotes the initiation of
DNA replication. In this issue of Cell, Mailand and Dif-
fley (2005) show that phosphorylation of Cdc6 by
cyclin-dependent kinases prevents its destruction by
the anaphase promoting complex (APC). This simple
mechanism explains how the APC simultaneously
spares Cdc6 while targeting for destruction suppres-
sors of DNA replication during the transition from qui-
escence to cell cycle reentry.
Eukaryotic cells have evolved extensive mechanisms to
ensure that DNA replication origins fire only once per
cell cycle. DNA replication is initiated by the assembly
of prereplication complexes in a process known as li-
censing (Diffley, 2004). During quiescence, when cells
have exited the cell cycle, the assembly of the prerepli-
cation complex is inhibited (Diffley, 2004; Blow and
Dutta, 2005). One of the crucial regulatory pathways al-
lowing cell cycle reentry following quiescence is the
timely and ordered destruction of prereplication-com-
plex inhibitors by the anaphase promoting complex
(APC) ubiquitin ligase (Diffley, 2004).
There are two forms of the APC: the mitotic form,
APCCdc20, containing the substrate-targeting subunit
Cdc20, and the nonmitotic form, APCCdh1, containing
the Cdc20 homolog Cdh1 (Harper et al., 2002). During
the G1 phase of the cell cycle, the nonmitotic form of
APC, APCCdh1, ensures prereplication-complex forma-
tion by degrading the inhibitors geminin and cyclin A
(McGarry and Kirschner, 1998; Peters, 2002; Diffley,
2004). Yet during quiescence, APCCdh1 also plays a
negative role in prereplication-complex assembly by
targeting the licensing activator Cdc6 for destruction.
These opposing roles for APCCdh1 in prereplication-
complex formation have generated both interest and
controversy (Diffley, 2004). The studies by Mailand and
Diffley (2005) (this issue of Cell) now provide an expla-
nation for how all three proteins can be APC substrates
during quiescence and cell cycle reentry.
The key to the model presented by Mailand and Dif-
fley is the temporal order for reaccumulation of these
substrates following quiescence. During quiescence,
Cdc6, geminin, and cyclin A are unstable. As cells reen-
ter the cell cycle, Cdc6 begins accumulating before
geminin and cyclin A. As a consequence, there is a
period of time when Cdc6 is active and induces prerep-
lication-complex formation before the accumulation of
the inhibitors that stop the process. But if Cdc6, gemi-
nin, and cyclin A are APC substrates and all are recog-
nized equally by the APC ubiquitin ligase, why would
production of geminin and cyclin A increase later than
Cell
826production of Cdc6 during G1? Mailand and Diffley ar-
gue that, in fact, geminin, cyclin A, and Cdc6 are not
equally recognized by APCCdh1 during cell cycle reentry.
The authors provide evidence that cyclin-dependent
kinases (CDKs) such as cyclin E-cdk2 prevent the de-
struction of Cdc6 by the APC. Most CDKs prevent pre-
replication-complex formation by inhibiting either the
assembly or activity of its components during the S,
G2, or mitosis phases of the cell cycle. Meanwhile,
other CDKs, such as those containing type E cyclin
subunits, do the opposite and promote cell cycle reen-
try (Geng et al., 2003). In the new study carried out in
cultured human cells, inhibition of cyclin E-cdk2 either
by treatment with the kinase inhibitor roscovotine or by
siRNA depletion of Cdk2 or cyclin E destabilizes Cdc6,
suggesting that cyclin E-cdk2 kinase activity is nega-
tively affecting Cdc6 turnover. In this model, stimulating
cell cycle reentry causes an increase in cyclin E, which
thereby increases the activity of cyclin E-cdk2, ulti-
mately leading to the stabilization of Cdc6 (Mailand and
Diffley, 2005; see Figure 1).
This study shows that the mechanism for Cdc6 stabi-
lization involves phosphorylation of Cdc6 by CDKs.
Cdc6 contains three serine phosphorylation sites in its
amino-terminal domain (Petersen et al., 2000). When
the authors mutate these sites to alanine (Cdc6 AAA),
Cdc6 is efficiently degraded in the presence of exoge-
nous cyclin E. However, mutation of all three serine res-
idues to aspartic acid (Cdc6 DDD) in order to mimic
phosphorylation stabilizes Cdc6 in the presence of ex-
cess cyclin E and during quiescence.
These findings prompted the authors to test whether
APCCdh1 recognition of Cdc6 is diminished by phos-
phorylation. This is an especially attractive hypothesis
given that the amino-terminal serines of Cdc6 are inter-
mingled with its two APCCdh1 recognition elements, a
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1Figure 1. APCCdh1 and Cyclin E-Cdk2 Have Opposing Effects on
Cdc6 Stabilization and Prereplication-Complex Assembly during
Cell Cycle Reentry from Quiescence
The essential licensing component Cdc6 is degraded during cellu-
lar quiescence through the action of APCCdh1, resulting in inhibition
of the assembly of the prereplication complex. Once cells are stim-
ulated to reenter the cell cycle, there is an increase in the activity
of the cyclin-dependent kinase cyclin E-cdk2. Cyclin E-cdk2 sub-
sequently phosphorylates the amino-terminal domain of Cdc6 dur-
ing mid-G1 phase of the cell cycle. Phosphorylated Cdc6 is stabi-
lized because APCCdh1 does not recognize it. Accumulation of
Cdc6 induces prereplication-complex assembly before the accu-
mulation of the inhibitors geminin and cyclin A in late G1 phase.
d
C
t
b
a
a
A
p
a
C
c
A
K
o
s
w
l
t
p
2
c
o
i
t
h
oestruction box and a KEN sequence. Both Cdc20 and
dh1 have been recently shown to capture the destruc-
ion box motif found in APC substrates, potentially
ringing substrates into close proximity with the ligase
nd the E2 (Burton et al., 2005; Kraft et al., 2005). The
uthors find that, whereas wild-type Cdc6 and Cdc6
AA interact with Cdh1 as judged by a coimmunopreci-
itation assay, the Cdc6 DDD mutant does not associ-
te efficiently. Furthermore, wild-type Cdc6 but not the
dc6 DDD mutant is robustly degraded in quiescent
ell extracts previously characterized as having high
PCCdh1 activity (Brandeis and Hunt, 1996; Rape and
irschner, 2004).
These findings are striking because APC recognition
f substrates was thought to be largely independent of
ubstrate phosphorylation status. In fact, this contrasts
ith work on SCF1, the other major class of ubiquitin
igase that is active throughout the cell cycle. Recogni-
ion by the F box component of the SCF ligase targets
hosphorylated substrates for degradation (Reed,
003; Petroski and Deshaies, 2005). Although Cdh1 re-
ognition of Cdc6 is inhibited by Cdc6 phosphorylation,
ne has to wonder whether other APC substrates are
n fact targeted more efficiently for degradation when
hey are phosphorylated. Furthermore, recent studies
ave demonstrated that the APC downregulates its
wn activity based on the availability of substrates dur-
ng G1 (Rape and Kirschner, 2004). If phosphorylation
y a kinase such as cyclin E-cdk2 affects substrate
evels, this could potentially affect the kinetics of APC
ownregulation and would couple two pathways pre-
iously thought to be independent.
Future studies will illuminate whether cyclin E-cdk2
ffects APC downregulation and whether the APCCdh1
nd cyclin E-cdk2 pathways have opposing roles in ini-
iating cell cycle reentry following quiescence. Consis-
ent with these ideas, the loss of the APC subunit APC2
n quiescent hepatocytes induces cell cycle reentry,
nd cyclin E-deficient cells are unable to reenter the
ell cycle from quiescence (Wirth et al., 2004; Geng et
l., 2003). If Cdc6 is indeed a major point of convergence
or these pathways, one would predict that overexpres-
ion of the Cdc6 DDD mutant in cyclin E-deficient cells
ay stimulate cell cycle reentry, as this mutant stimu-
ates MCM2 loading onto chromatin. We anxiously
wait the results of these and other experiments to de-
ermine whether the APC and cyclin E-cdk2 pathways
re indeed globally linked.
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Note Added in Proof
A recent paper by Duursma and Agami (2005) (Mol. Cell Biol. 25,
6937–6947) also reports a link between Cdc6 degradation and
cdk2 activity.
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